“The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency, has today (9 January) been quality-assured (prequalified) by the World Health Organization…

Prequalification is a mark of quality assurance granted by the WHO and will make it easier for more countries to access and use nOPV2.”

From News Medical.